Literature DB >> 4317987

Tissue NAD levels and the response to irradiation of cytotoxic drugs.

G Calcutt, S M Ting, A V Preece.   

Abstract

It has been shown that when (32)P counting from a tumour is continuous peaks in the count rate can sometimes be induced by large doses of nicotinic acid, nicotinic acid, nicotinamide or 3-acetylpyridine, but not by 6-aminonicotinamide. These (32)P counting peaks have been associated with the time of maximal new synthesis of nicotinamide adenine dinucleotide (NAD). Sensitization to irradiation or some cytotoxic drugs has been found at the peak of this new NAD synthesis. The radioprotective agents cysteamine, 2-aminoethylisothiouronium bromide (AET) and serotonin have been found to cause a rapid fall in tissue NAD levels. The results have been briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4317987      PMCID: PMC2008568          DOI: 10.1038/bjc.1970.44

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  TUMOUR SULPHYDRYL LEVELS AND SENSITIVITY TO THE NITROGEN MUSTARD MEROPHAN.

Authors:  G CALCUTT; T A CONNORS
Journal:  Biochem Pharmacol       Date:  1963-08       Impact factor: 5.858

2.  A technique for studying human tumour growth in vivo.

Authors:  B T HALE
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

3.  Significance of induced in vivo synthesis of diphosphopyridine nucleotide.

Authors:  L SHUSTER; T A LANGAN; N O KAPLAN; A GOLDIN
Journal:  Nature       Date:  1958-08-23       Impact factor: 49.962

4.  One-electron reactions in biochemical systems as studied by pulse radiolysis. I. Nicotinamide-adenine dinucleotide and related compounds.

Authors:  E J Land; A J Swallow
Journal:  Biochim Biophys Acta       Date:  1968-10-01

5.  An interpretation of the results of measurements of the uptake of 32P in human tumours.

Authors:  D M Taylor; R P Parker; E O Field; C A Greatorex
Journal:  Br J Radiol       Date:  1968-06       Impact factor: 3.039

6.  Changes in 32P counting-rate in human and animal tumours.

Authors:  A Woolley-Hart; P Twentyman; J Corfield; C Joslin; R Morrison; J F Fowler
Journal:  Br J Radiol       Date:  1968-06       Impact factor: 3.039

7.  In vivo studies of radioactive phosphorus in malignant tumours.

Authors:  N M Bleehen; T H Bryant
Journal:  Clin Radiol       Date:  1967-07       Impact factor: 2.350

8.  Quantitative biochemical differences between tumor and host as a basis for cancer chemotherapy. V. Niacin and 6-aminonicotinamide.

Authors:  D M SHAPIRO; L S DIETRICH; M E SHILS
Journal:  Cancer Res       Date:  1957-07       Impact factor: 12.701

9.  The continuous counting of phosphorus-32 from transplanted rat tumours and the effects of radiosensitisers and radioprotective agents.

Authors:  G Calcutt; M A Bullen; D H Marshall; T J Godden
Journal:  Br J Cancer       Date:  1967-06       Impact factor: 7.640

  9 in total
  2 in total

1.  Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

Authors:  M R Stratford; M F Dennis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.

Authors:  M R Horsman; D J Chaplin
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.